$COO 8-K SEC Filings

Filed On	Filing
27 Oct 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure Independent Director and Seasoned Healthcare Executive Walt Rosebrough
09 Sep 2026	8-K: Results of Operations and Financial Condition; Other Events San Ramon, Calif., September 9, 2026 — CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal third quarter ended July 31, 2026.
04 Jun 2026	8-K: Results of Operations and Financial Condition; Other Events
04 May 2026	8-K: Departure/Election of Directors or Officers; Compensation
08 Apr 2026	8-K: Submission of Matters to a Vote of Security Holders
05 Mar 2026	8-K: Results of Operations and Financial Condition
04 Feb 2026	8-K: Entry into a Material Definitive Agreement
23 Dec 2025	8-K: Entry into a Material Definitive Agreement; Departure/Election of Directors or Officers; Compensation +1 more
12 Dec 2025	8-K: Departure/Election of Directors or Officers; Compensation
04 Dec 2025	8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation +1 more
27 Aug 2025	8-K: Results of Operations and Financial Condition
29 May 2025	8-K: Results of Operations and Financial Condition
30 Apr 2025	8-K: Departure/Election of Directors or Officers; Compensation
02 Apr 2025	8-K: Submission of Matters to a Vote of Security Holders
06 Mar 2025	8-K: Results of Operations and Financial Condition
05 Feb 2025	8-K: Departure/Election of Directors or Officers; Compensation
05 Dec 2024	8-K: Results of Operations and Financial Condition
25 Oct 2024	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year
28 Aug 2024	8-K: Results of Operations and Financial Condition
30 May 2024	8-K: Results of Operations and Financial Condition

Comments